Abstract:Clinical epidemiologic data and animal experimental studies regard estrogen as being protective against the development of cardiovascular diseases. The mechanisms by which estrogen affects the development of vascular diseases are not clear. Recent studies demonstrated that the cardiovascular protective effects of estrogen are closely related to nitric oxide (NO) pathway. Our previous study proved that estrogen inhibited the proliferation and oncogene expression of vascular smooth muscle cells (VSMCs) induced by endothlin 1 (ET-1) and serum,this effect was mediated by NO release. In the present study, we investigated the role of inducible nitric oxide synthase (iNOS) in the VSMCs cycle arrest induced by 17 beta-estradiol (E(2)). The effects of E(2) on iNOS activity and protein expression in cultured rat VSMCs and the influence of NOS inhibitor N(G)-nitro-L-arginine methylester (L-NAME) on the inhibitory effect of E(2) on cell cycle were investigated. NOS assay kit was used to measure the activity of iNOS and protein expression of iNOS was determined by Western-blot. Cell cycle analysis was accessed by flow cytometry. The results obtained showed that E(2) increased iNOS activity of VSMCs but not in a dose-dependent manner. E(2) 10 nmol/L increased the iNOS activity of VSMCs distinctly at two time points: 30 min and 12 h. These effects were significantly inhibited by estrogen receptor (ER) antagonist Tamoxifen (0.1 micromol/L) and NOS inhibitor L-NAME (1 micromol/L). E(2) increased iNOS protein expression of VSMCs in a dose-dependent manner. The effect of E(2) on iNOS protein expression of VSMCs started at 3 h, distinctly increased at 12 h and then decreased. Tamoxifen significantly inhibited the E(2)-induced iNOS protein expression of VSMCs. ET-1 increased cell percentage of S phase and G(2)+S/G(1). This effect was inhibited by E(2). L-NAME significantly attenuated the inhibitory effect of E(2) on cell cycle of VSMCs. The results suggest that E(2) induced G(1) arrest of VSMCs, which was associated with an increase in iNOS activity and protein expression of VSMCs. These effects were at least mediated by estrogen receptor partly.

Dual effects of estrogen on vascular smooth muscle cells: receptor-mediated proliferative vs. metabolite-induced pro-senescent actions

17β-Estradiol inhibits oleic acid-induced rat VSMC Proliferation and migration by restoring PGC-1α expression

Effects of 17-β-Estradiol on Proliferation of Vascular Smooth Muscle Cells Induced by Thrombin and c-fos,Bcl-2 Expression

17β-Estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males

[Role of Inducible Nitric Oxide Synthase in the Vascular Smooth Muscle Cells Cycle Arrest Induced by 17 Beta-Estradiol].

Interaction of Hydrogen Sulfide and Estrogen on the Proliferation of Vascular Smooth Muscle Cells

17beta-estradiol inhibits oleic acid-induced rat VSMC proliferation and migration by restoring PGC-1alpha expression.

Estrogen accelerates G1 to S phase transition and induces a G2/M phase-predominant apoptosis in synthetic vascular smooth muscle cells.

Effect of estrogen on the proliferation of rat prostatic smooth muscle cells

Estrogen and Progesterone Inhibit Vascular Smooth Muscle Proliferation

Interaction among Estrogen, IGF-1, and H2S on Smooth Muscle Cell Proliferation

[Effect of ERK on 17Beta-Estradiol-induced Inhibition of VSMC Proliferation in Rats after Vascular Injury].

E0105 in Vitro Blockade of Oestrogen Receptor Promotes the Proliferation of Vascular Smooth Muscle Cells

Both Nongenomic and Genomic Effects Are Involved in Estradiol's Enhancing the Phenotype of Smooth Muscle Cells in Cultured Prostate Stromal Cells.

17SS-Estradiol Antagonizes the Down-Regulation of ERα/NOS-3 Signaling in Vascular Endothelial Dysfunction of Female Diabetic Rats.

17Β-Estradiol Nongenomically Induces Vascular Endothelial H2S Release by Promoting Phosphorylation of Cystathionine Γ-Lyase

17Β-Estradiol Promotes Angiogenesis of Rat Cardiac Microvascular Endothelial Cells in Vitro.

17β-Estradiol affects proliferation and apoptosis of rat prostatic smooth muscle cells by modulating cell cycle transition and related proteins

Estradiol improves cardiovascular function through up-regulation of SOD2 on vascular wall

17beta-estradiol affects proliferation and apoptosis of rat prostatic smooth muscle cells by modulating cell cycle transition and related proteins.

Mechanisms involved in the protective effect of estradiol-17beta on lipid peroxidation and DNA damage